Marchetti Francesco, Coleman Matthew A, Jones Irene M, Wyrobek Andrew J
Biosciences Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA.
Int J Radiat Biol. 2006 Sep;82(9):605-39. doi: 10.1080/09553000600930103.
To conduct a literature review of candidate protein biomarkers for individual radiation biodosimetry of exposure to ionizing radiation.
Reviewed approximately 300 publications (1973 - April 2006) that reported protein effects in mammalian systems after either in vivo or in vitro radiation exposure.
We found 261 radiation-responsive proteins including 173 human proteins. Most of the studies used high doses of ionizing radiation (>4 Gy) and had no information on dose- or time-responses. The majority of the proteins showed increased amounts or changes in phosphorylation states within 24 h after exposure (range: 1.5- to 10-fold). Of the 47 proteins that are responsive at doses of 1 Gy and below, 6 showed phosphorylation changes at doses below 10 cGy. Proteins were assigned to 9 groups based on consistency of response across species, dose- and time-response information and known role in the radiation damage response.
ATM (Ataxia telengiectasia mutated), H2AX (histone 2AX), CDKN1A (Cyclin-dependent kinase inhibitor 1A), and TP53 (tumor protein 53) are top candidate radiation protein biomarkers. Furthermore, we recommend a panel of protein biomarkers, each with different dose and time optima, to improve individual radiation biodosimetry for discriminating between low-, moderate-, and high-dose exposures. Our findings have applications for early triage and follow-up medical assessments.
对用于个体电离辐射生物剂量测定的候选蛋白质生物标志物进行文献综述。
查阅了约300篇出版物(1973年 - 2006年4月),这些文献报道了体内或体外辐射暴露后哺乳动物系统中的蛋白质效应。
我们发现了261种辐射反应性蛋白质,其中包括173种人类蛋白质。大多数研究使用高剂量电离辐射(>4 Gy),且没有关于剂量或时间反应的信息。大多数蛋白质在暴露后24小时内显示出含量增加或磷酸化状态改变(范围:1.5至10倍)。在47种对1 Gy及以下剂量有反应的蛋白质中,有6种在低于10 cGy的剂量下显示出磷酸化变化。根据跨物种反应的一致性、剂量和时间反应信息以及在辐射损伤反应中的已知作用,将蛋白质分为9组。
共济失调毛细血管扩张症突变基因(ATM)、组蛋白2AX(H2AX)、细胞周期蛋白依赖性激酶抑制剂1A(CDKN1A)和肿瘤蛋白53(TP53)是顶级候选辐射蛋白质生物标志物。此外,我们推荐一组蛋白质生物标志物,每种具有不同的最佳剂量和时间,以改善个体辐射生物剂量测定,用于区分低、中、高剂量暴露。我们的研究结果可应用于早期分诊和后续医学评估。